Role of thromboelastography in predicting and defining pump thrombosis in left ventricular assist device patients

Optimal anticoagulation for left ventricular assist device recipients aims to balance thrombosis and bleeding complications. Routine plasma-based coagulation tests may not accurately reflect overall hemostasis, and surrogate markers are used to help guide clinicians in the diagnosis of pump thrombosis. Thromboelastography derived coagulation index (CI) has been shown to be a parameter that can reflect “normocoagulability” in mechanical circulatory support device patients, but there is minimal data with regard to outcomes available.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Full Length Article Source Type: research